Ultrasensitive PAPP-A ELISA
$821.00
Catalog
55-PAPHUU-E01
The Ultrasensitive PAPP-A ELISA designed for the quantitative determination of PAPP-A in serum. Research Use Only. Not for Use in Diagnostic Procedures.
Mimimum order may be required.
Species
Human
Regulatory Status
Research Use Only. Not for Use in Diagnostic Procedures.
Product Distribution
Available Worldwide
Range
11.25 - 450 ng/mL
Sensitivity
0.023 ng/mL
Sample Types
Serum
Inc Time Minute
45
Inc Time Overnight
No
Inc Time See Protocol
No
Sample Size
100
Detection
Colorimetric
EDTA or Heparin cannot be used in this assay due to significant interferences.
The measurement of cardiac markers is essential for diagnosis, risk assessment and medical treatment of patients with acute coronary syndromes (ACS). In the last years increasing evidence was given that PAPP-A, a well-known marker for 1.Trimester Down-Syndrom Screening, is also increased in ACS patients, in particular in patients with instable coronary artery plaques. Importantly, elevated PAPP-A levels were also found in ACS patients with cTnI and/or CRP negative outcome. PAPP-A is therefore an independent marker for risk assessment and diagnosis in patients with ACS.
The measurement of cardiac markers is essential for diagnosis, risk assessment and medical treatment of patients with acute coronary syndromes (ACS). In the last years increasing evidence was given that PAPP-A, a well-known marker for 1.Trimester Down-Syndrom Screening, is also increased in ACS patients, in particular in patients with instable coronary artery plaques. Importantly, elevated PAPP-A levels were also found in ACS patients with cTnI and/or CRP negative outcome. PAPP-A is therefore an independent marker for risk assessment and diagnosis in patients with ACS.
